Nautilus Sues Wockhardt Over Cambia ANDA
Nautilus Neurosciences Inc. launched a patent infringement suit Friday in New Jersey, seeking to prevent Wockhardt Ltd. from selling a generic version of migraine drug Cambia....To view the full article, register now.
Already a subscriber? Click here to view full article